Cigna’s stock leads selloff among drug middlemen on breakup fears — but this analyst says it’s not a real risk

One influential healthcare analyst says the chances of such a bill passing are less than 5%.

Topics

Trump says FBI chief Wray’s resignation will ‘end the weaponization’ of justice department – US politics live

Christopher Wray will step down at the end of Biden’s presidency after Donald Trump said he wants Kash Patel to run the agency. The outgoing Senate minority leader, Mitch McConnell, has spoken ...
The Guardian - 53m
Super Micro executives sound upbeat — but the stock is still a sell, analyst says

Super Micro’s management helped assuage some concerns over customer orders, margins and liquidity, but J.P. Morgan is still bearish on the stock.
MarketWatch - 1d
C3.ai is still ‘extremely unprofitable’ so don’t buy the stock, analyst says

C3’s stock bounced back, but J.P. Morgan has a price target that implies a 35% downside.
MarketWatch - 1d
Amazon has caught up in the AI race, analysts say, and its stock surges to another record

Amazon’s stock was heading for a third straight record close Friday, as the company’s AWS re:Invent conference gave analysts reason to believe it has caught up with its AI rivals.
MarketWatch - 5d
Ulta Beauty’s stock on track for biggest gain in 2 years. One analyst says it’s still undervalued.

Beauty and cosmetics company’s latest earnings cheered investors and at least 17 analysts hiked stock price targets.
MarketWatch - 5d
Kevin Kisner will be the lead analyst for NBC's golf coverage

Kevin Kisner is the next lead analyst for NBC Sports
ABC News - Dec. 4
Kevin Kisner will be the lead analyst for NBC's golf coverage

Kevin Kisner is the next lead analyst for NBC Sports
ABC News - Dec. 4
Stocks and bonds haven’t moved together like this in three decades – and that’s putting portfolios at risk, says State Street

A so-called balanced portfolio is anything but given the correlation of stock and bond returns as well as concentration in stocks.
MarketWatch - Dec. 4

Cigna’s stock leads selloff among drug middlemen on breakup fears — but this analyst says it’s not a real risk

Topics

Related

Trump says FBI chief Wray’s resignation will ‘end the weaponization’ of justice department – US politics live

Super Micro executives sound upbeat — but the stock is still a sell, analyst says

C3.ai is still ‘extremely unprofitable’ so don’t buy the stock, analyst says

Amazon has caught up in the AI race, analysts say, and its stock surges to another record

Ulta Beauty’s stock on track for biggest gain in 2 years. One analyst says it’s still undervalued.

Kevin Kisner will be the lead analyst for NBC's golf coverage

Kevin Kisner will be the lead analyst for NBC's golf coverage

Stocks and bonds haven’t moved together like this in three decades – and that’s putting portfolios at risk, says State Street

More from MarketWatch

Here’s how much of a hit Microsoft is taking on its investment in GM’s Cruise

History suggests bitcoin could hit $150,000 in 2025 — but watch for these bumps ahead

Albertsons is now suing Kroger for billions. That won’t help it find another buyer, analysts say.

Adobe disappoints investors in this crucial metric, and shares fall nearly 9%

Nasdaq reaches 20,000 for the first time. Why that could spell trouble for investors in early 2025.